NCT07459543 2026-03-09
A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In India
Bristol-Myers Squibb
Phase 4 Not yet recruiting
Clinical Trials
12 trialsNCT07426484 2026-02-23
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Phase 4 Not yet recruiting
NCT07200544 2025-12-15
Meloxicam in Mohs Micrographic Surgery
University of Oklahoma
Phase 4 Recruiting
NCT00866684 2025-03-14
PROSKIN
Charite University, Berlin, Germany
Phase 4 Terminated
NCT06627036 2025-01-24
ClearMark
Hull University Teaching Hospitals NHS Trust
Phase 4 Recruiting
NCT06647342 2025-01-23
BLESS
Zealand University Hospital
Phase 4 Recruiting
NCT01856023 2023-12-05
PROCLIVITY02
Clinigen, Inc.
Phase 4 Terminated
NCT01459666 2022-05-26
Forehead Scars Following Mohs Micrographic Surgery and Reconstruction for Skin Cancer
University Hospitals Cleveland Medical Center
Phase 4 Terminated
NCT05359419 2022-05-04
Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper Extremities
Goldman, Butterwick, Fitzpatrick and Groff
Phase 4 Unknown
NCT01683188 2021-02-01
PROCLIVITY01
Clinigen, Inc.
Phase 4 Terminated
NCT00492895 2013-01-29
Photosensitivity of the Skin Under Azathioprin in Renal Transplant Recipients
University of Zurich
Phase 4 Completed
NCT00129961 2012-04-11
Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 4 Completed